Eucrates Biomedical Acqui... (EUCRU)
NASDAQ: EUCRU
· Real-Time Price · USD
10.02
-0.07 (-0.69%)
At close: Apr 26, 2023, 9:59 PM
Eucrates Biomedical Acquisition Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 18.86K | 60.04K | 104.77K | 159.07K | 49.16K | 206.22K | 383.23K | 443.25K |
Short-Term Investments | 12.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 105.42M | 104.95M | 104.83M | 104.84M | n/a | 104.82M | n/a |
Other Long-Term Assets | 12.35M | n/a | n/a | n/a | n/a | 104.83M | n/a | 104.82M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 37.2K | 117.4K | 197.08K | 215K | 284K | 363K | 443.75K |
Total Current Assets | 132.2K | 97.25K | 222.17K | 356.15K | 264.16K | 490.22K | 746.23K | 887K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 12.35M | 105.42M | 104.95M | 104.83M | 104.84M | 104.83M | 104.82M | 104.82M |
Total Assets | 12.49M | 105.52M | 105.18M | 105.18M | 105.11M | 105.32M | 105.56M | 105.71M |
Account Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 65.14K | 119.81K | 201.89K | 197.19K | n/a | 31.08K | 27.24K | 43.58K |
Total Current Liabilities | 65.14K | 119.81K | 201.89K | 197.19K | n/a | 31.08K | 27.24K | 43.58K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3.88M | 3.81M | 3.91M | 4.35M | n/a | 6.23M | 7.43M | 8.19M |
Total Long-Term Liabilities | 3.88M | 3.81M | 3.91M | 4.35M | n/a | 6.23M | 7.43M | 8.19M |
Total Liabilities | 3.95M | 3.93M | 4.11M | 4.55M | 5.8M | 6.27M | 7.46M | 8.23M |
Total Debt | 60.06K | 62.87K | 186.9K | 185.7K | n/a | n/a | n/a | n/a |
Common Stock | 12.25M | 105.32M | 104.85M | 104.8M | 104.8M | 104.8M | 100.41M | 100.41M |
Retained Earnings | -3.72M | -3.73M | -3.79M | -4.16M | -5.49M | -5.74M | -2.3M | -2.93M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 8.54M | 101.58M | 101.06M | 100.63M | -5.49M | 99.06M | 98.11M | 97.48M |
Total Investments | 12.35M | 105.42M | 104.95M | 104.83M | 104.84M | n/a | 104.82M | n/a |